Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone vs Sildenafil for PPHN in Neonates
NCT04391478Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of milrinone in persistent pulmonary hypertension of the newborn (PPHN) (2 arms). Primary endpoint: efficacy of milrinone versus sildenafil in treatment of PPHN. Started Jan 2015; status: completed.
02
Drugs
milrinone
03
Conditions
persistent pulmonary hypertension of the newborn (PPHN)
Beyond the preview
Go deeper on NCT04391478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04391478.